Research Article
Predicting Dyspnea Inducers by Molecular Topology
Table 1
Classification of compounds showing and not showing dyspnea, obtained by linear discriminant analysis on the training set.
| Compound | DF | Prob(A) | Class. | Compound | DF | Prob(A) | Class. |
| Active group |
| Adenosine | 2.259 | 0.905 | A | Mycophenolic acid | −1.514 | 0.18 | I | Amphotericin | 3.866 | 0.979 | A | Nelarabine | 3.177 | 0.96 | A | Anagrelide | 5.07 | 0.994 | A | Nicotine | 0.575 | 0.64 | A | Anastrozole | −2.044 | 0.115 | I | Nilutamide | −2.939 | 0.05 | I | Argatroban | 2.23 | 0.903 | A | Pentostatin | 2.321 | 0.911 | A | Atovaquone | −0.122 | 0.47 | I | Pergolide | 0.822 | 0.695 | A | Busulfan | 2.502 | 0.924 | A | Pindolol | 2.179 | 0.898 | A | Capecitabine | 2.054 | 0.886 | A | Porfimersodium | 1.69 | 0.844 | A | Cidofovir | 3.462 | 0.97 | A | Propafenone | 1.127 | 0.755 | A | Cyclosporine | 4.788 | 0.992 | A | Ribavirin | 2.928 | 0.949 | A | Daunorubicin | 2.559 | 0.928 | A | Risperidone | 1.021 | 0.735 | A | Dofetilide | 3.228 | 0.962 | A | Sprycel | 0.917 | 0.715 | A | Hycamtin | 1.16 | 0.762 | A | Tiagabine | −2.125 | 0.107 | I | Imatinib | 1.837 | 0.863 | A | Tobramycin | 4.012 | 0.982 | A | Irinotecan | 1.287 | 0.784 | A | Vinorelbine | 3.295 | 0.964 | A | Lenalidomide | −1.628 | 0.164 | I | Zoledronic acid | 2.792 | 0.942 | A | Mitoxantrone | 2.082 | 0.889 | A | | | | |
| Inactive group |
| Acitretin | −2.385 | 0.084 | I | Lamotrigine | −3.637 | 0.026 | I | Allopurinol | −1.102 | 0.249 | I | Latanoprost | −0.038 | 0.491 | I | Alprazolam | −2.209 | 0.099 | I | Leflunomide | −1.467 | 0.187 | I | Altretamine | −1.527 | 0.178 | I | Loratadine | −2.907 | 0.052 | I | Amlodipine | −0.004 | 0.499 | I | Lorazepam | −2.892 | 0.053 | I | Bexarotene | −2.322 | 0.089 | I | Mesalamine | −3.105 | 0.043 | I | Buspirone | 0.36 | 0.589 | A | Misoprostol | −0.17 | 0.458 | I | Carbamazepine | −4.109 | 0.016 | I | Nabilone | 1.131 | 0.756 | A | Carmustine | −4.441 | 0.012 | I | Nabumetone | −1.483 | 0.185 | I | Celecoxib | −1.132 | 0.244 | I | Naproxen | −4.037 | 0.017 | I | Chantix | 0.949 | 0.721 | A | Nicardipine | 0.558 | 0.636 | A | Clonazepam | −1.456 | 0.189 | I | Nitric oxide | −3.517 | 0.029 | I | Clozapine | 0.327 | 0.581 | A | Nitroglycerin | −3.265 | 0.037 | I | Cysteamine | −6.532 | 0.001 | I | Olanzapine | −0.006 | 0.499 | I | Deferasirox | 0.062 | 0.516 | A | Oxcarbazepine | −2.257 | 0.095 | I | Desloratadine | −2.321 | 0.089 | I | Oxybutynin | 0.131 | 0.533 | A | Desvenlafaxine | −1.86 | 0.135 | I | Phentermine | −1.992 | 0.12 | I | Diclofenac | −0.314 | 0.422 | I | Propofol | −2.077 | 0.111 | I | Didanosine | −0.853 | 0.299 | I | Riluzole | −5.256 | 0.005 | I | Entacapone | 0.009 | 0.502 | A | Ritonavir | −0.438 | 0.392 | I | Estazolam | −3.203 | 0.039 | I | Selegiline | −0.388 | 0.404 | I | Femara | −2.381 | 0.085 | I | Tacrine | −0.196 | 0.451 | I | Fenofibrate | −0.079 | 0.48 | I | Telbivudine | −0.065 | 0.484 | I | Flurbiprofen | −3.028 | 0.046 | I | Temazepam | −2.125 | 0.107 | I | Fluvoxamine | −2.285 | 0.092 | I | Temozolomide | 0.312 | 0.577 | A | Gabapentin | −4.73 | 0.009 | I | Terbinafine | 0.013 | 0.503 | A | Gadoversetamide | 0.613 | 0.649 | A | Thalidomide | −1.799 | 0.142 | I | Guanfacine | −6.447 | 0.002 | I | Theophylline anhydrous | 0.306 | 0.576 | A | Indomethacin | −1.603 | 0.168 | I | Valsartan | −3.183 | 0.04 | I | Iopromide | −0.36 | 0.411 | I | Venlafaxine | −0.794 | 0.311 | I | Isocarboxazid | −2.376 | 0.085 | I | Ziagen | −0.435 | 0.393 | I | Isradipine | −1.116 | 0.247 | I | Zidovudine | −1.208 | 0.23 | I | Ketoprofen | −3.277 | 0.036 | I | Zolmitriptan | −2.13 | 0.106 | I | Lamivudine | −3.59 | 0.027 | I | Zolpidem | 0.006 | 0.502 | A |
|
|
Prob(A): probability of activity. DF: discriminant function. Class.: clasiffication as active or inactive.
|